Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 519

Results For "IND"

6542 News Found

Manipal Hospitals deploys wearable technology to monitor post-surgery care
Hospitals | March 19, 2022

Manipal Hospitals deploys wearable technology to monitor post-surgery care

Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud


Thirty five generic manufacturers sign agreements with MPP for Paxlovid
News | March 18, 2022

Thirty five generic manufacturers sign agreements with MPP for Paxlovid

The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris


Merck discontinues KEYLYNK-101 trial to treat prostate cancer
Biotech | March 18, 2022

Merck discontinues KEYLYNK-101 trial to treat prostate cancer

At the interim analysis, the combination of Keytruda and Lynparza did not demonstrate a benefit in overall survival (OS), one of the study’s dual primary endpoints, compared to the control arm of either abiraterone acetate or enzalutamide


Health Canada authorizes Moderna's COVID-19 vaccine in children (6-11 Years)
News | March 18, 2022

Health Canada authorizes Moderna's COVID-19 vaccine in children (6-11 Years)

The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years


Sanofi moves forward with EUROAPI listing on Euronext Paris
Biotech | March 18, 2022

Sanofi moves forward with EUROAPI listing on Euronext Paris

EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions


USFDA approves Rinvoq for ulcerative colitis
Drug Approval | March 17, 2022

USFDA approves Rinvoq for ulcerative colitis

First approved in 2019, Rinvoq is a JAK inhibitor approved for four indications across gastroenterology, dermatology and rheumatology


Department of Pharmaceuticals release code to regulate medical devices sector
News | March 17, 2022

Department of Pharmaceuticals release code to regulate medical devices sector

If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code


Biological E gears up for new phase of vaccination drive
News | March 17, 2022

Biological E gears up for new phase of vaccination drive

To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India


Flipkart Health+ appoints Prashant Jhaveri as CEO
People | March 17, 2022

Flipkart Health+ appoints Prashant Jhaveri as CEO

Prashant comes with over 17 years of experience in the health, health insurance and other allied healthcare sectors


Community approach crucial to stamp out diseases
Public Health | March 17, 2022

Community approach crucial to stamp out diseases

The Karnataka Health Promotion Trust held a day-long session in New Delhi to address health care challenges